Lymphomatoid granulomatosis epidemiology and demographics: Difference between revisions
Kamal Akbar (talk | contribs) No edit summary |
Kamal Akbar (talk | contribs) No edit summary |
||
| Line 7: | Line 7: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
There is documentation on the incidence of this disease | |||
===Prevalence=== | ===Prevalence=== | ||
Prevalence of the diseases is unknown | |||
===Case-fatality rate/Mortality rate=== | ===Case-fatality rate/Mortality rate=== | ||
*The case-fatality rate/mortality rate of [disease name] is approximately [number range]. | *The case-fatality rate/mortality rate of [disease name] is approximately [number range]. | ||
Revision as of 17:29, 7 December 2018
|
Lymphomatoid granulomatosis Microchapters |
|
Differentiating Lymphomatoid granulomatosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Lymphomatoid granulomatosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Lymphomatoid granulomatosis epidemiology and demographics |
|
FDA on Lymphomatoid granulomatosis epidemiology and demographics |
|
CDC on Lymphomatoid granulomatosis epidemiology and demographics |
|
Lymphomatoid granulomatosis epidemiology and demographics in the news |
|
Blogs on Lymphomatoid granulomatosis epidemiology and demographics |
|
Directions to Hospitals Treating Lymphomatoid granulomatosis |
|
Risk calculators and risk factors for Lymphomatoid granulomatosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Lymphomatoid granulomatosis is a rare disease with which has prevalence that is not known. Its incidence is higher in males (male : female ratio 2 : 1), and it tends to occur between the 5th to 6th decade of life. It is more frequent in Europe than in Asia.[1]
Epidemiology and Demographics
Incidence
There is documentation on the incidence of this disease
Prevalence
Prevalence of the diseases is unknown
Case-fatality rate/Mortality rate
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- Patients of all age groups may develop [disease name].
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ Sýkorová A, Campr V, Kašparová P, Kočová E, Belada D, Trněný M; et al. (2014). "[Lymphomatoid granulomatosis - the past and present]". Vnitr Lek. 60 (3): 225–38. PMID 24981698.